Report Detail

Pharma & Healthcare Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2018

  • RnM2139435
  • |
  • 01 June, 2018
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2018

      1 Onychomycosis (Tinea Unguium) Drug Market Overview

      • 1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
      • 1.2 Onychomycosis (Tinea Unguium) Drug Segment by Type (Product Category)
        • 1.2.1 Global Onychomycosis (Tinea Unguium) Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Oral Type
        • 1.2.4 External Use Type
      • 1.3 Global Onychomycosis (Tinea Unguium) Drug Segment by Application
        • 1.3.1 Onychomycosis (Tinea Unguium) Drug Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Age under 18
        • 1.3.3 Age 18-50
        • 1.3.4 Age above 50
      • 1.4 Global Onychomycosis (Tinea Unguium) Drug Market by Region (2013-2025)
        • 1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Onychomycosis (Tinea Unguium) Drug (2013-2025)
        • 1.5.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production Status and Outlook (2013-2025)

      2 Global Onychomycosis (Tinea Unguium) Drug Market Competition by Manufacturers

      • 2.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Onychomycosis (Tinea Unguium) Drug Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
        • 2.5.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
        • 2.5.2 Onychomycosis (Tinea Unguium) Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Onychomycosis (Tinea Unguium) Drug Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Onychomycosis (Tinea Unguium) Drug Production and Market Share by Region (2013-2018)
      • 3.3 Global Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Onychomycosis (Tinea Unguium) Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Onychomycosis (Tinea Unguium) Drug Consumption by Region (2013-2018)
      • 4.2 North America Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2013-2018)

      5 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Onychomycosis (Tinea Unguium) Drug Production and Market Share by Type (2013-2018)
      • 5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2013-2018)
      • 5.4 Global Onychomycosis (Tinea Unguium) Drug Production Growth by Type (2013-2018)

      6 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Application

      • 6.1 Global Onychomycosis (Tinea Unguium) Drug Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Onychomycosis (Tinea Unguium) Drug Manufacturers Profiles/Analysis

      • 7.1 Johnson & Johnson
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 GSK
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 GSK Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Novartis
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Pfizer
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Valeant Pharma
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Kaken Pharmaceutical
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Galderma
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Xiuzheng Pharmaceutical
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 Letai
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 Letai Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.10 Qilu Pharmaceutical
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
        • 7.10.4 Main Business/Business Overview

      8 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis

      • 8.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2025)

      • 12.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Onychomycosis (Tinea Unguium) Drug Price and Trend Forecast (2018-2025)
      • 12.2 Global Onychomycosis (Tinea Unguium) Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Onychomycosis (Tinea Unguium) Drug market status and forecast, categorizes the global Onychomycosis (Tinea Unguium) Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

        The global Onychomycosis (Tinea Unguium) Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

        The major manufacturers covered in this report
        Johnson & Johnson
        GSK
        Novartis
        Pfizer
        Valeant Pharma
        Kaken Pharmaceutical
        Galderma
        Xiuzheng Pharmaceutical
        Letai
        Qilu Pharmaceutical

        Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Oral Type
        External Use Type
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Age under 18
        Age 18-50
        Age above 50

        The study objectives of this report are:
        To analyze and study the global Onychomycosis (Tinea Unguium) Drug sales, value, status (2013-2017) and forecast (2018-2025).
        Focuses on the key Onychomycosis (Tinea Unguium) Drug manufacturers, to study the sales, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Onychomycosis (Tinea Unguium) Drug are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Onychomycosis (Tinea Unguium) Drug Manufacturers
        Onychomycosis (Tinea Unguium) Drug Distributors/Traders/Wholesalers
        Onychomycosis (Tinea Unguium) Drug Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Onychomycosis (Tinea Unguium) Drug market, by end-use.
        Detailed analysis and profiles of additional market players.


        Summary:
        Get latest Market Research Reports on Onychomycosis (Tinea Unguium) Drug . Industry analysis & Market Report on Onychomycosis (Tinea Unguium) Drug is a syndicated market report, published as Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2018. It is complete Research Study and Industry Analysis of Onychomycosis (Tinea Unguium) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $5,800.00
        2,127.99
        4,255.99
        2,390.42
        4,780.84
        301,199.80
        602,399.60
        212,110.93
        424,221.86
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report